Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1502 of 5804
-
Italian MS patients on mayzent show promise in slowing disability over 3 years
Disease control CompletedThis is an observational, multicenter, single-arm, prospective study conducted in Italy
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New lung cancer vaccine trial launches for advanced patients
Disease control Recruiting nowThis first-in-human (FIH) study for BNT116 aims to establish the safety profile and a safe dose for BNT116 monotherapy as well as for BNT116 in combination with approved medicinal products and/or in combination with investigational medicinal products (IMPs) including, but not lim…
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New cocktail of cancer drugs shows promise for tough lymphoma
Disease control OngoingThe primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin, glofitamab, or mosunetuzumab, and to identify the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE) for the…
Phase: PHASE1 • Sponsor: ADC Therapeutics S.A. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Writing away HIV risk: trauma therapy boosts PrEP in Drug-Using women
Prevention OngoingThe goal of this randomized controlled trial is to test the effectiveness of "TIARAS," a trauma intervention designed to reduce HIV acquisition risk among women who inject drugs (WWID). To be eligible for this study, participants must have been prescribed pre-exposure prophylaxis…
Phase: NA • Sponsor: Drexel University • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
FSHD drug trial halted midway: what happened?
Disease control TerminatedThis is a study to evaluate the safety and efficacy of losmapimod in treating participants with Facioscapulohumeral Muscular Dystrophy (FSHD). Participants diagnosed with Facioscapulohumeral muscular dystrophy type 1 (FSHD1) or Facioscapulohumeral muscular dystrophy type 2 (FSHD2…
Phase: PHASE3 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a drug let kids with EoE eat eggs and milk again? small trial aims to find out.
Disease control CompletedEosinophilic Esophagitis (EoE) is a food driven non-immunoglobulin E (IgE) mediated disease involving eosinophils and type 2 inflammation. Current therapies include diet and the off label use of medications including proton pump inhibitors, topical steroids or biologics. Food eli…
Phase: PHASE4 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New vaccine AFX3772 aims to shield infants from pneumonia
Prevention CompletedThis is a Phase 2 clinical study to support the use of AFX3772 in healthy infants for the prevention of pneumococcal disease. The purpose of this study is to determine the safety, tolerability, and immunogenicity of 3 different formulations of AFX3772 compared with Prevnar 13 (PC…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
Could zapping the brain help treat anorexia?
Symptom relief OngoingAnorexia nervosa is a severe psychiatric disorder associated with food avoidance and body image distortion, that is feeling fat despite being underweight. It is the third most common chronic illness among adolescent females, and its mortality reaches its peak between the ages 16 …
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 26, 2026 12:33 UTC
-
Vibrating muscles may rewire brains after injury
Knowledge-focused Recruiting nowSequences of muscle tendon vibrations allow to reproduce the sensory feedback during movement like locomotion and kinaesthesia. It is known that such a treatment promotes motor recovery after stroke assuming that it enhances neuroplasticity. The aim of the research is to study th…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could a smaller HPV vaccine dose still protect adults?
⭐️ VACCINE ⭐️ OngoingThis randomized phase IV trial compares intramuscular and intradermal fractional dose of bivalent HPV vaccine to fractional dose of nonavalent HPV vaccine among men and women aged 27-45 years in Seattle, Washington. Participants will have immune response assessed at baseline, 4 w…
Phase: PHASE4 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Could a pill cut falls in Parkinson's? new trial investigates
Symptom relief CompletedThis is a Phase 2b study investigating the efficacy and safety of pirepemat as adjunct therapy on falls frequency in patients with Parkinson disease. Pirepemat is taken for 84 days.
Phase: PHASE2 • Sponsor: Integrative Research Laboratories AB • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Bubble contrast could reveal prostate cancer without a needle
Diagnosis OngoingThis phase III trial investigates if perflutren lipid microspheres with ultrasound can be used to diagnose prostate cancer non-invasively. Definity (perflutren lipid microspheres) is an ultrasound contrast agent that is typically used for ultrasound bubble studies that involve th…
Phase: PHASE3 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 26, 2026 13:45 UTC
-
New hope for kidney patients: experimental drug targets protein leak
Disease control CompletedThis is a Phase 2, Multi-center, Open-Label Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of R3R01 in Alport Syndrome Patients with Uncontrolled Proteinuria on ACE/ARB Inhibition and in Patients with Primary Steroid-Resistant Focal Segmental Glomeruloscleros…
Phase: PHASE2 • Sponsor: River 3 Renal Corp. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Sound waves could ease Parkinson's tremors without drugs
Symptom relief CompletedThe study will test the feasibility of using Low Intensity Focused Ultrasound Pulsation (LIFUP) to treat motor symptoms in Parkinson's Disease (PD). LIFUP is a new technique that can increase brain activity in highly specific target areas and is MRI compatible. Thus, in real-time…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Phone app boosts HIV treatment in men using stimulants
Disease control CompletedThis Phase II randomized controlled trial is testing the efficacy of a cell phone application called START for helping men who use stimulants like methamphetamine to get the most out of their HIV treatment.
Phase: NA • Sponsor: Florida International University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New vaccine aims to block deadly botulism toxin
Prevention CompletedA Phase 2, randomized, double-blind, placebo-controlled single or repeat dose trial
Phase: PHASE2 • Sponsor: U.S. Army Medical Research and Development Command • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Could a 'Sinus poop Transplant' cure chronic sinusitis? new trial says maybe.
Disease control OngoingChronic sinusitis (CRS) is a common inflammatory condition of the sinuses that affects up to 2.5% of the Canadian population, and is thought to be caused by bacterial infection, resistant biofilms, chronic inflammation and possibly an unhealthy population of sinus microbes (or mi…
Phase: NA • Sponsor: Amin Javer • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Herbal hope: can a traditional decoction boost immunotherapy for Bone-Metastatic lung cancer?
Disease control Recruiting nowThis is a double-blind, randomized controlled study evaluating the efficacy and safety of HGXJT in combination with ICI-based standard treatment in lung cancer patients with bone metastases. Enrolled participates will randomly receive HGXJT or placebo during the first 4-6 cycles …
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Steroid combo may improve tough lung fungus treatment
Disease control Recruiting nowWhile ABPA and CPA represent two distinct manifestations of Aspergillus-related lung disease, there is an overlap of investigations that are currently used for the diagnosis of these entities. In a previous study, the authors have demonstrated that 22% of subjects with CPA fulfil…
Phase: NA • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug cocktail shows promise for Hard-to-Treat myeloma
Disease control OngoingThis phase II trial studies the effect of isatuximab, carfilzomib, and pomalidomide in treating patients with multiple myeloma that has come back (relapsed) or does not respond to treatment (refractory). Isatuximab is a monoclonal antibody that may interfere with the ability of c…
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC